US4432971A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Phosphonamidate compounds
Assignee: ER Squibb and Sons LLC
•
Filing: 1982-06-28
•
Granted: 1984-02-21
•
Expires: 2002-06-28
Abstract
Abstract Phosphonamidates of the formula <IMAGE> wherein X is a substituted or unsubstituted imino or amino acid or ester. These compounds possess angiotensin converting enzyme activity and are thus useful as hypotensive agents.
Inventors
- 👤 Donald S. Karanewsky
- 👤 Edward W. Petrillo, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 04:37
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/572; B; B01; B01J; B01J19/00; B01J19/18; B01J19/1806; C07F9/28; C07F9/38; C07F9/44; C07F9/4461; C07F9/4465; C07F9/568; C07F9/576; C07F9/59; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
233 words
A compound of the formula ##STR321## and a pharmaceutically acceptable salt thereof wherein: Y is oxygen or sulfur and the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent; R 1 is hydrogen, lower alkyl, or cycloalkyl; R 2 is hydrogen, lower alkyl, halo substituted lower alkyl, ##STR322## or R 1 and R 2 taken together are --(CH 2 ) n -- wherein n is an integer from 2 to 4; R 3 and R 6 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and ##STR323## wherein R 17 is hydrogen, lower alkyl, cycloalkyl, or phenyl, and R 18 is hydrogen, lower alkyl, lower alkoxy, phenyl or R 17 and R 18 taken together are ##STR324## R 13 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; r is an integer from 1 to 4; q is zero or an integer from 1 to 7; s is an integer from 1 to 8; and p is one, two or three provided that p is more than one only if R 13 is hydrogen, methyl, methoxy, chloro, or fluoro.
Claim 2
Dependent Claim
233 words
A compound of the formula ##STR321## and a pharmaceutically acceptable salt thereof wherein: Y is oxygen or sulfur and the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent; R 1 is hydrogen, lower alkyl, or cycloalkyl; R 2 is hydrogen, lower alkyl, halo substituted lower alkyl, ##STR322## or R 1 and R 2 taken together are --(CH 2 ) n -- wherein n is an integer from 2 to 4; R 3 and R 6 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and ##STR323## wherein R 17 is hydrogen, lower alkyl, cycloalkyl, or phenyl, and R 18 is hydrogen, lower alkyl, lower alkoxy, phenyl or R 17 and R 18 taken together are ##STR324## R 13 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; r is an integer from 1 to 4; q is zero or an integer from 1 to 7; s is an integer from 1 to 8; and p is one, two or three provided that p is more than one only if R 13 is hydrogen, methyl, methoxy, chloro, or fluoro.
Claim 3
Dependent Claim
206 words
A compound of claim 1 wherein: Y is oxygen or sulfur and the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a methyl or dimethyl substituent; R 1 is hydrogen or lower alkyl of 1 to 4 carbons; R 2 is hydrogen, lower alkyl of 1 to 4 carbons, CF 3 , or amino substituted lower alkyl of 1 to 4 carbons, or R 1 and R 2 taken together are --(CH 2 ) 3 --; R 21 is alkyl of 1 to 10 carbons, ##STR325## --(CH 2 ) q --cycloalkyl wherein cycloalkyl is of 5 or 6 carbons, ##STR326## R 3 and R 6 are independently selected from the group consisting of hydrogen, alkali metal salt, lower alkyl of 1 to 4 carbons, and ##STR327## R 17 is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or cyclohexyl; R 18 is straight or branched chain lower alkyl of 1 to 4 carbons or phenyl; R 13 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, or hydroxy; q is zero or an integer from 1 to 4; and s is an integer from 1 to 8.
Claim 4
Dependent Claim
32 words
A compound of the claim 2 of the formula ##STR328## wherein: Y is oxygen or sulfur; t is two or three; and R 6 is hydrogen, ##STR329## or an alkali metal salt.
Claim 5
Dependent Claim
37 words
A compound of claim 3 wherein R 1 is hydrogen or methyl; R 2 is hydrogen, methyl, or --(CH 2 ) 4 --NH 2 ; and R 3 is hydrogen, ethyl, ##STR330## or an alkali metal salt.
Claim 6
Dependent Claim
15 words
A compound of claim 4 wherein R 21 is alkyl of 1 to 10 carbons.
Claim 7
Dependent Claim
33 words
A compound of claim 4 wherein R 21 is ##STR331## q is zero or an integer from 1 to 4, and R 13 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, or hydroxy.
Claim 8
Dependent Claim
9 words
A compound of claim 6 wherein X is ##STR332##
Claim 9
Dependent Claim
35 words
The compound of claim 7 wherein R 21 is ##STR333## R 1 is hydrogen; R 2 is methyl; R 3 and R 6 are the same and both are hydrogen or an alkali metal salt.
Claim 10
Dependent Claim
24 words
A compound of claim 4 wherein R 21 is --(CH 2 ) s --NH 2 and s is an integer from 1 to 8.
Claim 11
Dependent Claim
58 words
A composition useful for treating hypertension in a mammalian specie comprising a pharmaceutically acceptable carrier and an effective amount of a hypotensive agent or pharmaceutically acceptable salt thereof of the formula ##STR334## wherein R 1 , R 2 , R 3 , R 6 , R 21 , Y, and R 16 are as defined in claim 1.
Claim 12
Dependent Claim
9 words
The composition of claim 10 also including a diuretic.
Claim 13
Dependent Claim
21 words
The method of alleviating hypertension in a mammalian specie which comprises administering an effective amount of the composition of claim 10.
References Cited (Backward Citations)
US4053651A
Cited
US4199512A
Cited
US4105776A
Cited
US4192878A
Cited
BE868532A
Cited
US4151172A
Cited
US4129566A
Cited
US4154935A
Cited
GB2027025A
Cited
US4316906A
Cited
US4316896A
Cited
US4168267A
Cited
US4256751A
Cited
US4311697A
Cited
US4217359A
Cited
GB2048863A
Cited
US4234489A
Cited
US4256761A
Cited
US4256761B1
Cited
US4296113A
Cited
US4310461A
Cited
US4316905A
Cited
US4296033A
Cited
US4337201A
Cited
US4379146A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-02-20 | 1987-08-22 | 1988-02-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-02-20 | 1991-08-22 | 1992-02-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-02-20 | 1995-08-22 | 1996-02-21 | $7700.00 | Window Closed / Lapsed |